Recently, the Guangzhou Gobroad Research Hospital topped out. This innovative research-oriented international hospital is located in the Sino-Singapore Guangzhou Knowledge City Bio-Safety Industry Base.
The hospital is a research-oriented tertiary comprehensive hospital covering an area of approximately 40,000 square meters. The Phase I construction area is around 90,000 sq m, including outpatient and emergency departments, inpatient departments, medical technology departments, and laboratory areas.
The rendering of the Guangzhou Gobroad Research Hospital. [Photo/WeChat account: guangzhougaoxinqu]
Guangzhou Gobroad Research Hospital specializes in pediatric and adult hematologic diseases, solid tumors, and rare diseases. It plans to have 550 beds, with 80 percent dedicated to conducting clinical trials of innovative drugs and medical devices from domestic and international sources.
Once completed, the project plans to conduct over 100 high-level clinical trials annually, including cutting-edge projects like cell and gene therapy. This initiative will significantly accelerate the market entry of innovative drugs and medical devices, promote the transformation of high-quality bio-industry projects, and fill a crucial gap in the development of the regional pharmaceutical and health industry.
In the future, this project will provide clinical transformation and application scenarios for innovative drugs and medical devices, promoting the coordinated development of the entire bio-pharmaceutical industry chain within the region. It will propel Guangzhou to a higher level of global competition within the biopharmaceutical industry.